Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma

Journal of Small Animal Practice

Volumn 40, Issue 7, 1999, Pages 326-331

  Stockhaus, C ^a   Kohn, B ^a   Rudolph, R ^a   Brunnberg, L ^a   Giger, U ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR;

ADENOCARCINOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CLOTTING TEST; CANCER STAGING; CARCINOMA; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; HEMOSTASIS; ISOLATION AND PURIFICATION; PATHOLOGY; REFERENCE VALUE; RISK;

ADENOCARCINOMA; ANIMALS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CARCINOMA; DOG DISEASES; DOGS; FEMALE; HEMOSTASIS; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM STAGING; REFERENCE VALUES; RISK;

EID: 0033160393     PISSN: 00224510     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-5827.1999.tb03090.x     Document Type: Article

References (47)

1. AUGER, M. J., GALLOWAY, M. J., LEINSTER, S. J., MCVERRY, B. A. & M. J. MACKIE (1987) Elevated fibrinopeptid A levels in patients with clinically localised breast carcinoma. Hemostasis 17, 336-339
2. AUGER, M. J. & MACKIE, M. J. (1987) Monocyte procoagulant activity in breast cancer. Thrombosis Research 47, 77-84
3. BELT, R. J., LEITE, C., HAAS, C. D. & STEPHENS, R. L. (1978) Incidence of hemorrhagic complications in patients with cancer. Journal of the American Medical Association 239, 2571-2574
4. BITHELL, T. C. (1993) Thrombosis and antithrombotic therapy. In: Wintrobe's Clinical Hematology, 9th edn. Eds G. R. Lee, T. C. Bithell, J. Foerster, J. W. Athens and J. N. Lukens. Lea & Febiger, Philadelphia. pp 1515-1551
5. BRAIN, M. C., AZZOPARDI, J. G., BAKER, L. R. I., PINEO, G. F., ROBERTS, P. D. & DACIE, J. V. (1969) Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma. British Journal of Haematology 18, 183-193
6. CLAUSS, A. (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematologica (Basel) 17, 237-246
7. COLMAN, R. W. & RUBIN, R. N. (1990) Disseminated intravascular coagulation due to malignancy. Seminars in Oncology 17, 172-186
8. DONATI, M. B. (1994) Cancer and thrombosis. Haemostasis 24, 128-131
9. DONATI, M. C., SEMERARO, N. S. & GORDON, S. G. (1984) Relationship between procoagulant activity and metastatic capacity of tumor cells. In: Hemostatic mechanisms and metastasis. Eds K. V. Honn and B. F. Sloane. Martinus Nijhoff, Boston. pp 84-95
10. DVORAK, H. F. (1986) Tumors: wounds that do not heal. New England Journal of Medicine 315, 1686-1695
11. DVORAK, H. F. (1987) Thrombosis and cancer. Human Pathology 18, 275-284
12. EDWARDS, R. L., RICKLES, F. R., MORITZ, T. E., HENDERSON, W. G., ZACHARSKI, L. R., FORMAN, W. B., CORNELLI, C. J., FORCIER, R. J., O'DONNELL, J. F., HEADLEY, E., KIM, S. H., O'DELL, R., TORNYOS, K. & KWAAN, H. C. (1987) Abnormalities of blood coagulation tests in patients with cancer. American Journal of Clinical Pathology 88, 596-602
13. GOODNOUGH, L. T., SAITO, H., MANNI, A., JONES, P. K. & PEARSON, O. H. (1984) Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. Cancer 54, 1264-1268
14. GRINDEM, C. B., BREITSCHWERDT, E. B., CORBETT, W. T., PAGE, R. L. & JANS, H. E. (1994) Thrombocytopenia associated with neoplasia in dogs. Journal of Veterinary Internal Medicine 8, 400-405
15. HAMMER, A. S., COUTO, C. G., SWARTSON, C. & GETZY, D. (1991) Hemostatic abnormalities in dogs with hemangiosarcoma. Journal of Veterinary Internal Medicine 5, 11-14
16. HONEGGER, H., ANDERSON, N., HEWITT, L. A. & TULLIS, J. L. (1981) Antithrombin III profiles in malignancy: relationship to primary tumors and metastatic sites. Thrombosis Haemostasis 46, 500-503
17. KAMMERMANN, B., GMÜR, J. & STÜNZI, H. (1971) Afibrinogenämie beim Hund. Zentralblatt Veterinärmedizinische Reihe A 18, 192-205
18. KIES, M. S., POSCH, J. J., GIOLMA, J. P. & RUBIN, R. N. (1980) Hemostatic function in cancer patients. Cancer 46, 831-837
19. LINDAHL, A. K., SANDSET, P. M., ABBILDGAARD, U., ANDERSON, T. R. & HARBITZ, T. B. (1989) High levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer. Acta Chirurgica Scandinavica 155, 389-393
20. LOHRMANN, H. P., ADAM, W., HEYME, B. & KUBANEK, B. (1973) Microangiopathic hemolytic anemia in metastatic carcinoma. Annals of Internal Medicine 79, 368-375
21. LUZATTO, G. & SCHAFER, A. I. (1990) The prethrombotic state in cancer. Seminars in Oncology 17, 147-159
22. MACHOVIC, R. (1987) Role of blood coagulation-fibrinolytic system and endothelial cells in malignancy. In: Hemostasis and Cancer. Ed L. Muszbek. CRC Press, Boca Raton, Florida. pp 4-17
23. MADEWELL, B. R., FELDMAN, B. F. & O'NEILL, S. (1980) Coagulation abnormalities in dogs with neoplastic disease. Thrombosis Diathesis Haemorrhagica 44, 35-38
24. MANNUCCI, P. M., VAGLINE, M., MANIEZZO, M., MAGNI, E., MARI, D. & CASCINIELLI, N. (1985) Hemostatic alterations are unrelated to the stage of tumor in untreated malignant melanoma and breast cancer. European Journal of Cancer and Clinical Oncology 21, 681-685
25. MILLER, S. P., SANCHEZ-AVALOZ, J., STEFANSKI, T. & ZUCKERMAN, L. (1967) Coagulation disorders in cancer. Cancer 20, 1452-1465
26. MISCHKE, R. (1993) Einfluß der Faktor VIII:C-Aktivität auf die aktivierte partielle Thromboplastinzeit (aPTT) beim Hund-Eignung der aPTT als Screeningtest für die canine Hämophilie A? Deutsche Tierärztliche Wochenschrift 107, 289-294
27. MISCHKE, R. (1994) Methodische Aspekte für die koagulometrische Aktivitätsbestimmung der Gerinnungsfaktoren II, V, VII und X aus Hundeplasma. Journal of Veterinary Medicine Series A 41, 587-598
28. MISCHKE, R. (1995) Hämostase. In: Klinische Labordiagnostik in der Tiermedizin. Eds W. Kraft and U. M. Dürr. Schattauer, Stuttgart. pp 84-103
29. MISCHKE, R., WOHLSEIN, P., BUSSE, L. & POHLENZ, J. (1998) Verbrauchskoagulopathie und Hyperfibrinolyse bei Hunden mit metastasierendem Mammakarzinom. Schweizer Archiv für Tierheilkunde 140, 497-505
30. NAGY, I. & LOSONCZY, H. (1987) Hemostatic alterations in malignancies and lymphomas. In: Hemostasis and Cancer. Ed L. Muszbek. CRC Press, Boca Raton, Florida. pp 243-248
31. O'DONNELL, M. R., SLICHTER, S. J., WEIDEN, P. L. & STORB, R. (1981) Platelet and fibrinogen kinetics in canine tumors. Cancer 41, 1379-1383
32. OETJEN, S. (1992) Untersuchung zur plasmatischen Gerinnung gesunder Hunde. Veterinary Dissertation, Hannover, Germany
33. O'KEEFE, D. A. & COUTO, C. G. (1988) Coagulation abnormalities associated with neoplasia. Veterinary Clinics of North America: Small Animal Practice 18, 157-168
34. OWEN, L. N. (1980) TNM Classification of Tumors of Domestic Animals. Geneva, World Health Organization
35. PETERSON, H. I., KJARTANSSON, I., KORSAN-BENGTSEN, K., RUDENSTAM, C. M. & ZETTERGREN, L. (1973) Fibrinolysis in human malignant tumors. Acta Chirurgica Scandinavica 139, 219-223
36. PEUSCHER, F. W., CLETON, F. J., ARMSTRONG, L., STOEPMAN-VAN DALEN, E. A., VAN MOURIK, J. A. & VAN AKEN, W. G. (1980) Significance of plasma fibrinopeptide A (fpA) in patients with malignancy. Journal of Laboratory Clinical Medicine 96, 5-14
37. RICKLES, F. R., EDWARDS, R. L., BARB, C. & CRONLUND, M. (1983) Abnormalities of blood coagulation in cancer. Cancer 51, 301-307
38. ROCHA, E., PARAMO, J. A., FERNANDEZ, F. J., CUESTA, B., HERNANDEZ, M., PALOMA, M. J., RIFON, J. & ROCHA, E. (1989) Clotting activation and impairment of fibrinolysis in malignancy. Thrombosis Research 54, 699-707
39. SACHS, L. (1992) Angewandte Statistik. Ed. L. Sachs. Springer, Berlin. pp 114-116
40. SLAPPENDEL, R. J. (1988a) Disseminated intravascular coagulation. Veterinary Clinics of North America: Small Animal Practice 18, 169-184
41. SLAPPENDEL, R. J. (1988b) Disseminated intravascular coagulation associated with neoplasia. Veterinary Clinics of North America: Small Animal Practice 18, 271-271
42. SLAPPENDEL, R. J., VAN ARKEL, C., MIEOG, W. H. W. & BOUMA, B. N. (1972) Response to heparin of spontaneous disseminated intravascular coagulation in the dog. Zentralblatt Veterinärmedizin Serie A 19, 502-513
43. SUN, N. C. J., MCAFEE, W. M., HUM, G. J. & WEINER, J. M. (1979) Hemostatic abnormalities in malignancy, a prospective study of 108 patients. Part I Coagulation studies. American Journal of Clinical Pathology 71, 10-16
44. SUSANECK, S. J., ALLEN, T. A., HOOPES, J., WITHROW, S. J. & MACY, D. W. (1983) Inflammatory carcinoma in the dog. Journal of the American Animal Hospital Association 19, 971-976
45. WEISS, D. J. (1984) Uniform evaluation and semi-quantitative reporting of hematologic data in veterinary laboratories. Veterinary Clinical Pathology 13, 27-31
46. ZACHARSKI, L. R., WOJTUKIEWICZ, M. Z., COSTATINI, V., ORNSTEIN, D. L. & MEMOLI, V. A. (1992) Pathways of coagulation/fibrinolysis activation in malignancy. Seminars in Thrombosis and Haemostasis 18, 104-116
47. ZURBORN, K. H. (1989) Spontane und Zytostatikainduzierte Gerinnungsstörungen bei Malignompatienten. In: Gerinnung und Fibrinolyse. Ed N. Heimburger. Die Medizinische Verlagsgesellschaft, Marburg. pp 95-101